[HTML] frontiersin.org

[HTML][HTML] Bax/Bcl-2 cascade is regulated by the EGFR pathway: therapeutic targeting of non-small cell lung cancer

M Alam, S Alam, A Shamsi, M Adnan… - Frontiers in …, 2022 - frontiersin.org
Non-small cell lung carcinoma (NSCLC) comprises 80%–85% of lung cancer cases. EGFR
is involved in several cancer developments, including NSCLC. The EGFR pathway …
被引用次数：50 相关文章
[PDF] researchgate.net

[PDF][PDF] Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer. Front

M Alam, S Alam, A Shamsi, M Adnan, AM Elasbali… - Oncol, 2022 - researchgate.net
Non-small cell lung carcinoma (NSCLC) comprises 80%–85% of lung cancer cases. EGFR
is involved in several cancer developments, including NSCLC. The EGFR pathway …
[HTML] nih.gov

[HTML][HTML] Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer

M Alam, S Alam, A Shamsi, M Adnan… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Non-small cell lung carcinoma (NSCLC) comprises 80%–85% of lung cancer cases. EGFR
is involved in several cancer developments, including NSCLC. The EGFR pathway …

Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer.

M Alam, S Alam, A Shamsi, M Adnan… - Frontiers in …, 2022 - europepmc.org
Non-small cell lung carcinoma (NSCLC) comprises 80%–85% of lung cancer cases. EGFR
is involved in several cancer developments, including NSCLC. The EGFR pathway …
[HTML] frontiersin.org

[HTML][HTML] Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer

M Alam, S Alam, A Shamsi, M Adnan… - Frontiers in …, 2022 - frontiersin.org
Non-small cell lung carcinoma (NSCLC) comprises 80%–85% of lung cancer cases. EGFR
is involved in several cancer developments, including NSCLC. The EGFR pathway …

Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer

M Alam, S Alam, A Shamsi, M Adnan, AM Elasbali… - Frontiers in …, 2022 - cir.nii.ac.jp
抄録< jats: p> Non-small cell lung carcinoma (NSCLC) comprises 80%–85% of lung cancer
cases. EGFR is involved in several cancer developments, including NSCLC. The EGFR …

Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer

M Alam, S Alam, A Shamsi, M Adnan… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Non-small cell lung carcinoma (NSCLC) comprises 80%-85% of lung cancer cases. EGFR is
involved in several cancer developments, including NSCLC. The EGFR pathway regulates …

Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer.

M Alam, S Alam, A Shamsi, M Adnan… - Frontiers in …, 2022 - europepmc.org
Non-small cell lung carcinoma (NSCLC) comprises 80%–85% of lung cancer cases. EGFR
is involved in several cancer developments, including NSCLC. The EGFR pathway …